Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies
about
Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammationA C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagyNeuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation.The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan.Restoration of intestinal function in an MPTP model of Parkinson's Disease.Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling.LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease.The role of neuroimmune signaling in alcoholism.Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.MicroRNAs in Parkinson's disease and emerging therapeutic targets.Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway.Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disordersNLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
P2860
Q27301100-38B5F15C-EB27-484A-98A6-2FCFEE090082Q29465530-4799C78F-1D83-478E-93C7-AA53AA84958EQ32178128-BE4A3274-26E9-4045-B856-6FCF74A27CDFQ33731341-90764369-9255-4E94-A297-60B5E27EB739Q34508284-D8D2076F-A78A-4F26-98B7-901B90138E92Q36184308-AD933371-01E2-46E9-9017-FABDF07761EEQ36346103-4607334A-1DF7-4C3A-82C1-C400E1B8F704Q36566963-FF634E20-47F5-46D8-B507-9C2F508424F2Q37137476-E088FCCF-603E-4125-9C58-184116EABFE3Q37198050-E382A137-6659-41E3-9701-2851A019BCB3Q37394743-4629E651-257E-4B35-856F-5E959C9F73AFQ37583930-F8C83288-B4D6-474F-A95B-17E41C920499Q37604710-FF22A029-D8AC-44E5-BF4D-5A8CC905B60FQ38623708-9C3F8F57-3E20-46C5-91AB-6F5987F3B958Q39118808-EE3CF56E-413A-43F2-94CB-67B28F6E68DEQ41000187-BB65181C-BFA3-444B-9C13-473C51669636Q41349377-7F3AD569-103F-4114-900C-B73DC6D55CB3Q47335457-B9EEB388-6D46-4B16-8D37-EE0707A1F960Q47392210-8DC8109B-1BB3-4E8F-BC61-22CE54D64094Q47868304-BD5868F8-4629-4A32-97F9-AC1192F44231Q47870847-A55BEEED-7114-4C14-908B-E7C180FC6238Q48362528-E796C38C-8F57-4549-9D0B-05B951C24177Q55023794-ACA4122F-098A-4282-9B13-D547934092B3Q55152170-29C1DF8A-53A1-4347-9A49-87CEA44E060DQ55379242-BF618DE3-A53D-42B7-9514-9889E12F7B81Q58763366-56400E17-CA27-4A62-9CFB-8B3749A7815CQ58778263-E57DE54B-1FB1-4675-9553-2675A00E9300
P2860
Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@ast
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@en
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@nl
type
label
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@ast
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@en
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@nl
prefLabel
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@ast
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@en
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@nl
P2860
P921
P3181
P356
P1476
Insights into Neuroinflammatio ...... i-Inflammatory Based Therapies
@en
P2093
Aline Silva de Miranda
P2860
P304
P3181
P356
10.1155/2015/628192
P407
P5008
P577
2015-07-29T00:00:00Z